HIGHLIGHTS
- who: o from the the Netherlands Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands have published the paper: Cardiac function in childhood cancer survivors treated with vincristine: Echocardiographic results from the DCCSS LATER 2 CARD study, in the Journal: (JOURNAL)
- what: Since the authors aimed to evaluate the effects of vincristine, the authors excluded CCS who received other potentially cardiotoxic therapy as well. This study focuses on CCS treated with vincristine as the only potentially cardiotoxic agent. It is encouraging that none of the CCS in this study reported . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.